CCEP - Coca-Cola Europacific Partners PLC
NASDAQ
->
Consumer Defensive
->
Beverages—Non-Alcoholic
Uxbridge,
United Kingdom
Type: Equity
CCEP price evolution
CCEP
| (in millions $) | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 | 1 Aug 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $2728 | $3068 | $2690 | $2861 |
| Inventory | $1356 | $1714 | $1380 | $1410 |
| Total current assets | $6605 | $7458 | $6543 | $6978 |
| Long term investments | ||||
| Property, plant & equipment | $5344 | $5077 | $5201 | $5164 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $29254 | $29795 | $29313 | $30354 |
| Current liabilities | ||||
| Accounts payable | $5234 | $5476 | $5052 | $5075 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $7278 | $8766 | $7313 | $7416 |
| Long term debt | $10096 | $9332 | $10571 | $11065 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $21278 | $22035 | $21866 | $22763 |
| Shareholders' equity | ||||
| Retained earnings | $7695 | $7490 | $7208 | $7361 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $465 | $491 | $708 | $1739.72 |
| Short term investments | ||||
| Net receivables | $2728 | $2690 | $2494 | $1815.12 |
| Inventory | $1356 | $1380 | $1157 | $777.91 |
| Total current assets | $6605 | $6543 | $5760 | $4656.02 |
| Long term investments | ||||
| Property, plant & equipment | $5344 | $5201 | $5248 | $4409.28 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $17318.41 | |||
| Total investments | ||||
| Total assets | $29254 | $29313 | $29090 | $21974.43 |
| Current liabilities | ||||
| Accounts payable | $2306 | $2191 | $1691 | $3352.65 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $7278 | $7313 | $6093 | $4729.12 |
| Long term debt | $10096 | $10571 | $11790 | $7290.16 |
| Total noncurrent liabilities | $10362.95 | |||
| Total debt | ||||
| Total liabilities | $21278 | $21866 | $22057 | $15092.07 |
| Shareholders' equity | ||||
| Retained earnings | $8441 | $7635 | $6969 | $6942.9 |
| Other shareholder equity | -$746 | -$427 | -$161 | -$285.58 |
| Total shareholder equity | ||||
| (in millions $) | 29 Jul 2021 | 30 Apr 2021 | 29 Jul 2020 | 29 Jul 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 | 30 Jan 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12115.23 | $13459.04 | $13602.76 | $12503.38 |
| Cost of revenue | ||||
| Gross Profit | $4266.49 | $5144.16 | $5264.9 | $4848.99 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $3338.54 | $3411.28 | $3730.46 | $3425.2 |
| Operating income | $928.69 | $1733.76 | $1535.3 | $1424.18 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $225.03 | $407.68 | $349.58 | $532.37 |
| Interest expense | $164.49 | $162.4 | $165.34 | $167.28 |
| Net income | ||||
| Net income | $568.87 | $1220.8 | $1073.53 | $777.65 |
| Income (for common shares) | ||||
| (in millions $) | 29 Jul 2021 | 29 Jul 2020 | 29 Jul 2019 | 30 Jan 2019 |
|---|---|---|---|---|
| Net income | $548.23 | $232.33 | $762.07 | $1423.11 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $1094.05 | $388.69 | $948.66 | $2132.89 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$6345 | -$266.47 | -$329.33 | -$703.88 |
| Financing activities | ||||
| Dividends paid | -$325.96 | -$605.85 | ||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $5558.2 | $527.43 | -$537.27 | -$1486.88 |
| Effect of exchange rate | $55.43 | -$14.31 | -$2.36 | |
| Change in cash and equivalents | $362.67 | $635.33 | $82.05 | -$60.23 |
| (in millions $) | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 | 30 Jan 2018 |
|---|---|---|---|---|
| Net income | $793.9 | $1628.48 | $1423.11 | $1310.02 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $1702.03 | $2132.48 | $2132.89 | $1834.48 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$422.65 | -$670.88 | -$703.88 | -$551.59 |
| Financing activities | ||||
| Dividends paid | -$440.93 | -$642.88 | -$605.85 | -$552.72 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $114.23 | -$1458.24 | -$1486.88 | -$1302.11 |
| Effect of exchange rate | -$14.85 | $4.48 | -$2.36 | -$10.17 |
| Change in cash and equivalents | $1378.76 | $7.84 | -$60.23 | -$29.39 |
News
Fundamentals
| Market cap | $33.90B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 459.20M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.91 |
| Quick ratio | 0.72 |